TNF and Alzheimer disease: Only pre-incubation using the EP4 receptor antagonist (MF498) completely reversed PGE2-suppressive effects on monocyte TNFα secretion from patients with AD/ACLF, with no additional effect when EP2/4 inhibitors were combined (Fig. 6C).